Tripterifordin

CAS No. 139122-81-9

Tripterifordin( —— )

Catalog No. M23548 CAS No. 139122-81-9

Tripterifordin shows anti-HIV replication activity in H9 lymphocyte cells with an EC50 of 1 microgram/ml.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 475 In Stock
10MG 680 In Stock
25MG 1017 In Stock
50MG 1377 In Stock
100MG 1782 In Stock
500MG 3735 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tripterifordin
  • Note
    Research use only, not for human use.
  • Brief Description
    Tripterifordin shows anti-HIV replication activity in H9 lymphocyte cells with an EC50 of 1 microgram/ml.
  • Description
    Tripterifordin shows anti-HIV replication activity in H9 lymphocyte cells with an EC50 of 1 microgram/ml.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    139122-81-9
  • Formula Weight
    318.5
  • Molecular Formula
    C20H30O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C[C@@]12[C@]3([H])[C@@](COC1=O)(CCC2)[C@@]4([H])[C@]5(C[C@@]([C@](C)(O)C5)([H])CC4)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Anti-AIDS agents, 4. Tripterifordin, a novel anti-HIV principle from Tripterygium wilfordii: isolation and structural elucidation.J Nat Prod. 1992 Jan;55(1):88-92.
molnova catalog
related products
  • NBD-557

    A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction; inhibits the fusion between HIV-1NL4-3-luc pseudotyped virus expressing HIV-1HXB2 (X4-tropic) envelope and U87-T4-CXCR4 cells with IC50 of 9.7 uM.

  • SAMT-247

    SAMT-247 potent HIV-1 nucleocapsid protein NCp7 inhibitor with EC50 of 0.6 uM with low cellular toxicity (TC50>100 uM) in cultured and primary cells.

  • Atazanavir sulfate

    A highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.